BRCA testing in unaffected young women in the United States, 2006‐2017

Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark

(2018) Shan Yang et al.   ANNALS OF SURGICAL ONCOLOGY

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

(2018) Peter D. Beitsch et al.   JOURNAL OF CLINICAL ONCOLOGY

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B. Kuchenbaecker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Underuse of BRCA testing in patients with breast and ovarian cancer

(2016) Jason D. Wright et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

BRCA1andBRCA2Mutation Testing in Young Women With Breast Cancer

(2016) Shoshana M. Rosenberg et al.   JAMA Oncology

Is it time to offer BRCA1 and BRCA2 testing to all Jewish women?

(2015) K.A. Metcalfe et al.   Current Oncology

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

(2015) Johnathan M. Lancaster et al.   GYNECOLOGIC ONCOLOGY

A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment

(2014) Heather Hampel et al.   GENETICS IN MEDICINE

Population-Based Screening forBRCA1andBRCA2

(2014) Mary-Claire King et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Quality of Cancer Family History and Referral for Genetic Counseling and Testing Among Oncology Practices: A Pilot Test of Quality Measures As Part of the American Society of Clinical Oncology Quality Oncology Practice Initiative

(2014) Marie E. Wood et al.   JOURNAL OF CLINICAL ONCOLOGY

Precision Medicine Meets Public Health: Population Screening for BRCA1 and BRCA2

(2014) E. Levy-Lahad et al.   JNCI-Journal of the National Cancer Institute

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

(2013) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

(2013) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Primary Care Physician Management, Referral, and Relations with Specialists Concerning Patients at Risk for Cancer due to Family History

(2013) M.E. Wood et al.   Public Health Genomics

Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers

(2012) Brian Drohan et al.   ANNALS OF SURGICAL ONCOLOGY

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

(2012) Kathryn Alsop et al.   JOURNAL OF CLINICAL ONCOLOGY

Social and ethical implications of BRCA testing

(2011) A. Surbone   ANNALS OF ONCOLOGY

Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

(2011) Douglas E Levy et al.   GENETICS IN MEDICINE

Expanding the Criteria forBRCAMutation Testing in Breast Cancer Survivors

(2010) Janice S. Kwon et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

(2010) Mark E. Robson et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA mutations in the management of breast cancer: the state of the art

(2010) Steven A. Narod   Nature Reviews Clinical Oncology

Too Many Referrals of Low-Risk Women for BRCA1/2 Genetic Services by Family Physicians

(2008) D. B. White et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION